Ixempra Kit
Product Images NDC 70020-1910

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ixempra (NDC 70020-1910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by R-pharm Us Operating, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ixe00 0000 01)

FDA Label Image

Figure 1 (Ixe00 0000 02)

FDA Label Image

Ixe00 0000 03 2

XEMPRA (xabepilone) is a medication for intravenous infusion only. Each carton contains a vial of 15mg injection and a vial of 8mL diluent for reconstitution and dilution that needs to be refrigerated. The medication has to be reconstituted and diluted before use. This description is about the usage and storage of XEMPRA (xabepilone).*

FDA Label Image

Ixe00 0000 04 2

FDA Label Image

Ixe00 0000 05 2

This is a medication called IXEMPRA containing 15mg of Ixabepilone. The medication must be reconstituted and diluted with specific infusion fluids before use. Any unused portion should be discarded and the medication must be refrigerated at 2°C to 8°C (36°F to 46°F) in its original package and protected from light. It is a hazardous drug, and recommended dosage should be obtained from the enclosed insert. The medication is made in Germany and distributed by B-Pham US LLC based in Princeton, NJ, USA.*

FDA Label Image

Ixe00 0000 06 2

IXEMPRA is a hazardous drug that comes in a single-dose vial containing 45mg of ixabepilone. It should be reconstituted and diluted with one of the specified infusion fluids before administration. The unused portion must be discarded, and the drug should be refrigerated at 2°C to 8°C (36°F to 46°F) in the original package, protected from light. Reconstitution instructions are included in the insert. IXEMPRA is for intravenous infusion only and is distributed by R-Pharm US LLC in Princeton, NJ.*

FDA Label Image

Ixe00 0000 07 2

This is a medication that contains polyoxyethylated castor oil and dehydrated alcohol. It is only intended for dilution of IXEMPRA (iabepilone) injection and is not for direct administration. The instructions for preparation and administration can be found in the insert. This medication should be stored in its original package at 2°C to 8°C and protected from light. Unused portion should be discarded. It is distributed by R-Pham US LLC from Princeton, NJ and made in Germany.*

FDA Label Image

Ixe00 0000 08 2

This text describes the diluent used for the IXEMPRA injection. It contains polyoxyethylated castor oil and dehydrated alcohol. The diluent is specifically for dilution and not intended for direct administration. The package insert includes preparation and administration instructions. The unused portion should be discarded and the diluent should be refrigerated and protected from light. The diluent is made in Germany and distributed by R-Pharm US LLC in Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.